NCT03236675View on ClinicalTrials.gov

Detection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCLC Patients

UnknownOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Carcinoma, Non-Small-Cell Lung
Trial Locations (2)

33021

Memorial Healthcare System, Hollywood

70121

Ochsner Medical Center, New Orleans

Sponsors
All Listed Sponsors
lead

Exosome Diagnostics, Inc.

INDUSTRY

NCT03236675 - Detection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCLC Patients | Biotech Hunter | Biotech Hunter